Paying users zone. Data is covered by .

  • Get to Allergan PLC for $13.99, or

  • get to whole website for at least 3 months from $49.99.

  2. Allergan PLC
  3. Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity
 

$13.99

Allergan PLC (AGN)

Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity

Difficulty: Beginner

Allergan PLC, Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Accrued third-party rebates                    
Contractual commitments, including amount due to Teva                    
Accrued payroll and related benefits                    
Accrued returns                    
Interest payable                    
Royalties payable                    
Accrued pharmaceutical fees                    
Accrued R&D expenditures                    
Accrued severance, retention and other shutdown costs                    
Litigation-related reserves and legal fees                    
Accrued non-provision taxes                    
Current portion of contingent consideration obligations                    
Accrued selling and marketing expenditures                    
Dividends payable                    
Other accrued expenses                    
Accrued expenses % % % % %
Accounts payable                    
Accounts payable and accrued expenses % % % % %
Income taxes payable                    
Current portion of long-term debt and capital leases                    
Deferred revenue                    
Current liabilities held for sale                    
Deferred tax liabilities                    
Current liabilities % % % % %
Long-term debt and capital leases, excluding current portion                    
Acquisition related contingent consideration liabilities                    
Long-term pension and post retirement liability                    
Legacy Allergan deferred executive compensation                    
Long-term severance and restructuring liabilities                    
Deferred revenue                    
Product warranties                    
Long-term contractual obligations                    
Litigation-related reserves                    
Other long-term liabilities                    
Other long-term liabilities % % % % %
Long-term liabilities held for sale                    
Other taxes payable                    
Deferred tax liabilities                    
Non current liabilities % % % % %
Total liabilities % % % % %
Preferred shares, $0.0001 par value per share                    
Ordinary shares; $0.0001 par value per share                    
Additional paid-in capital                    
Retained earnings (accumulated deficit)                    
Accumulated other comprehensive income (loss)                    
Treasury stock, at cost                    
Shareholders' equity % % % % %
Noncontrolling interest                    
Total equity % % % % %
Total liabilities and equity % % % % %

Top

Stock Analysis on Net